Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Molecular typing of Treponema pallidum causing early syphilis in China: a cross-sectional study.

Peng RR, Yin YP, Wei WH, Wang HC, Zhu BY, Liu QZ, Zheng HP, Zhang JP, Huang SJ, Chen XS.

Sex Transm Dis. 2012 Jan;39(1):42-5. doi: 10.1097/OLQ.0b013e318232697d.

PMID:
22183845
2.

Getting the measure of syphilis: qPCR to better understand early infection.

Tipple C, Hanna MO, Hill S, Daniel J, Goldmeier D, McClure MO, Taylor GP.

Sex Transm Infect. 2011 Oct;87(6):479-85. doi: 10.1136/sti.2011.049494. Epub 2011 Jul 12.

3.

Cell and tissue interactions of Treponema pallidum in primary and secondary syphilitic skin lesions: an ultrastructural study of serial sections.

Juanpere-Rodero N, Martin-Ezquerra G, Fernandez-Casado A, Magan-Perea L, Garcia-Alguacil MA, Barranco-Sanz C, Serrano-Figueras S, Pujol-Vallverdu RM, Lloreta-Trull J.

Ultrastruct Pathol. 2013 Feb;37(1):36-42. doi: 10.3109/01913123.2011.584498. Epub 2011 Jul 7.

PMID:
21736426
4.

TpF1 from Treponema pallidum activates inflammasome and promotes the development of regulatory T cells.

Babolin C, Amedei A, Ozolins D, Zilevica A, D'Elios MM, de Bernard M.

J Immunol. 2011 Aug 1;187(3):1377-84. doi: 10.4049/jimmunol.1100615. Epub 2011 Jun 27.

5.

Discordant results from reverse sequence syphilis screening--five laboratories, United States, 2006-2010.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2011 Feb 11;60(5):133-7.

6.

Sexually transmitted diseases treatment guidelines, 2010.

Workowski KA, Berman S; Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2010 Dec 17;59(RR-12):1-110. Erratum in: MMWR Recomm Rep. 2011 Jan 14;60(1):18. Dosage error in article text.

7.

Bifunctional role of the Treponema pallidum extracellular matrix binding adhesin Tp0751.

Houston S, Hof R, Francescutti T, Hawkes A, Boulanger MJ, Cameron CE.

Infect Immun. 2011 Mar;79(3):1386-98. doi: 10.1128/IAI.01083-10. Epub 2010 Dec 13.

8.

Host defense mechanisms in secondary syphilitic lesions: a role for IFN-gamma-/IL-17-producing CD8+ T cells?

Stary G, Klein I, Brüggen MC, Kohlhofer S, Brunner PM, Spazierer D, Müllauer L, Petzelbauer P, Stingl G.

Am J Pathol. 2010 Nov;177(5):2421-32. doi: 10.2353/ajpath.2010.100277. Epub 2010 Oct 1.

9.

Surface immunolabeling and consensus computational framework to identify candidate rare outer membrane proteins of Treponema pallidum.

Cox DL, Luthra A, Dunham-Ems S, Desrosiers DC, Salazar JC, Caimano MJ, Radolf JD.

Infect Immun. 2010 Dec;78(12):5178-94. doi: 10.1128/IAI.00834-10. Epub 2010 Sep 27.

10.

Enhanced molecular typing of treponema pallidum: geographical distribution of strain types and association with neurosyphilis.

Marra C, Sahi S, Tantalo L, Godornes C, Reid T, Behets F, Rompalo A, Klausner JD, Yin Y, Mulcahy F, Golden MR, Centurion-Lara A, Lukehart SA.

J Infect Dis. 2010 Nov 1;202(9):1380-8. doi: 10.1086/656533.

11.

Cellular architecture of Treponema pallidum: novel flagellum, periplasmic cone, and cell envelope as revealed by cryo electron tomography.

Liu J, Howell JK, Bradley SD, Zheng Y, Zhou ZH, Norris SJ.

J Mol Biol. 2010 Nov 5;403(4):546-61. doi: 10.1016/j.jmb.2010.09.020. Epub 2010 Sep 17.

12.

Azithromycin treatment failure among primary and secondary syphilis patients in Shanghai.

Zhou P, Li K, Lu H, Qian Y, Gu X, Gong W, Tucker JD, Cohen MS.

Sex Transm Dis. 2010 Nov;37(11):726-9. doi: 10.1097/OLQ.0b013e3181e2c753.

13.

Molecular epidemiology of syphilis--San Francisco, 2004-2007.

Katz KA, Pillay A, Ahrens K, Kohn RP, Hermanstyne K, Bernstein KT, Ballard RC, Klausner JD.

Sex Transm Dis. 2010 Oct;37(10):660-3. doi: 10.1097/OLQ.0b013e3181e1a77a.

PMID:
20601928
14.

Secondary syphilis in cali, Colombia: new concepts in disease pathogenesis.

Cruz AR, Pillay A, Zuluaga AV, Ramirez LG, Duque JE, Aristizabal GE, Fiel-Gan MD, Jaramillo R, Trujillo R, Valencia C, Jagodzinski L, Cox DL, Radolf JD, Salazar JC.

PLoS Negl Trop Dis. 2010 May 18;4(5):e690. doi: 10.1371/journal.pntd.0000690.

15.

A phase III equivalence trial of azithromycin versus benzathine penicillin for treatment of early syphilis.

Hook EW 3rd, Behets F, Van Damme K, Ravelomanana N, Leone P, Sena AC, Martin D, Langley C, McNeil L, Wolff M.

J Infect Dis. 2010 Jun 1;201(11):1729-35. doi: 10.1086/652239.

PMID:
20402591
16.

CXCL13 as a cerebrospinal fluid marker for neurosyphilis in HIV-infected patients with syphilis.

Marra CM, Tantalo LC, Sahi SK, Maxwell CL, Lukehart SA.

Sex Transm Dis. 2010 May;37(5):283-7. doi: 10.1097/OLQ.0b013e3181d877a1.

17.

Antigenic variation in Treponema pallidum: TprK sequence diversity accumulates in response to immune pressure during experimental syphilis.

Giacani L, Molini BJ, Kim EY, Godornes BC, Leader BT, Tantalo LC, Centurion-Lara A, Lukehart SA.

J Immunol. 2010 Apr 1;184(7):3822-9. doi: 10.4049/jimmunol.0902788. Epub 2010 Feb 26.

18.

Cerebrospinal fluid human immunodeficiency virus viral load in patients with neurosyphilis.

de Almeida SM, Bhatt A, Riggs PK, Durelle J, Lazzaretto D, Marquie-Beck J, McCutchan A, Letendre S, Ellis R.

J Neurovirol. 2010 Feb;16(1):6-12. doi: 10.3109/13550280903514776.

19.

Syphilis co-infection does not affect HIV disease progression.

Weintrob AC, Gu W, Qin J, Robertson J, Ganeson A, Crum-Cianflone NF, Landrum ML, Wortmann GW, Follman D, Agan BK.

Int J STD AIDS. 2010 Jan;21(1):57-9. doi: 10.1258/ijsa.2009.009164. Epub 2009 Nov 20.

PMID:
19933204
20.

Cryo-electron tomography elucidates the molecular architecture of Treponema pallidum, the syphilis spirochete.

Izard J, Renken C, Hsieh CE, Desrosiers DC, Dunham-Ems S, La Vake C, Gebhardt LL, Limberger RJ, Cox DL, Marko M, Radolf JD.

J Bacteriol. 2009 Dec;191(24):7566-80. doi: 10.1128/JB.01031-09. Epub 2009 Oct 9.

Supplemental Content

Support Center